TORONTO - Visionary Holdings Inc. (NASDAQ:GV), a Canadian private education provider with a focus on artificial intelligence and life science technology, has announced a partnership with Red Sun Group, a leading company in China. This collaboration is set to establish a life sciences conglomerate in Toronto, aiming to create the world's largest platform for the nicotinamide and anti-aging NMN (nicotinamide mononucleotide) industries.
The partnership plans to develop a complete industry chain from raw materials to various end products, including functional foods, skincare, animal health products, and potential future medical products. The initiative intends to serve a global market comprising cosmetics, food manufacturing, animal products, pharmaceuticals, and medical institutions, as well as end consumers.
Visionary Holdings and Red Sun Group are leveraging the latter's expertise in nicotinamide and NMN production and technology. The collaboration is expected to meet the increasing global and Canadian market demand for health-related products, particularly those addressing anti-aging and skin whitening.
The market for NMN, a compound associated with anti-aging and longevity, is expected to grow significantly. The current market size is valued at $5 billion as of 2023 and is projected to reach $12.93 billion by 2031, with a compound annual growth rate of 9.1% from 2024 to 2031.
InvestingPro Insights
In light of Visionary Holdings Inc.'s recent partnership with Red Sun Group, investors and industry observers are closely monitoring the company's financial metrics. The latest data from InvestingPro reveals some noteworthy figures that might interest stakeholders. Visionary Holdings currently boasts a market capitalization of $24.8 million USD, indicating a relatively modest size within the industry yet showing potential for growth especially in niche markets such as NMN products.
The company's revenue growth is particularly striking, with a 197.4% increase over the last twelve months as of Q2 2024, and a quarterly growth rate of 165.72% in Q2 2024. This rapid expansion could be attributed to the burgeoning demand for anti-aging and health-related products, a sector where Visionary Holdings is positioning itself through the partnership with Red Sun Group.
InvestingPro Tips suggest that the significant EBITDA growth of 1579.52% in the same period is a positive signal of the company's increasing profitability before depreciation, interest, taxes, and amortization are factored in. This aligns with the company's strategic moves to capture a share of the NMN market, which is projected to experience robust growth in the coming years.
Moreover, with a PEG Ratio of 0.04, Visionary Holdings appears to be undervalued relative to its earnings growth, making it a potentially attractive investment. For investors seeking more in-depth analysis and additional InvestingPro Tips, InvestingPro offers a comprehensive suite of tools and insights. There are 23 more tips available on InvestingPro for those who want to delve deeper into Visionary Holdings' financial health and prospects. To access these tips and more, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.